XyloCor Therapeutics

XyloCor wraps up PhII for heart disease gene therapy, plans for pivotal trial
Endpoints
Fri, 01/27/23 - 10:31 am
XyloCor Therapeutics
gene therapy
heart disease
clinical trials
XyloCor bags $23M to expand heart disease gene therapy R&D
Fierce Biotech
Mon, 03/22/21 - 10:46 am
XyloCor Therapeutics
gene therapy
VEGF
heart disease
clinical trials
R&D
Angina gene therapy company XyloCor raises $17M series A round
BioCentury
Sun, 12/9/18 - 03:45 pm
XyloCor Therapeutics
angina
gene therapy